These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30288066)

  • 1. Effects of oral probiotic supplementation on gut
    Strus M; Helwich E; Lauterbach R; Rzepecka-Węglarz B; Nowicka K; Wilińska M; Szczapa J; Rudnicka M; Sławska H; Szczepański M; Waśko A; Mikołajczyk-Cichońska A; Tomusiak-Plebanek A; Heczko PB
    Infect Drug Resist; 2018; 11():1557-1571. PubMed ID: 30288066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Short-Time Probiotic Supplementation on the Abundance of the Main Constituents of the Gut Microbiota of Term Newborns Delivered by Cesarean Section-A Randomized, Prospective, Controlled Clinical Trial.
    Hurkala J; Lauterbach R; Radziszewska R; Strus M; Heczko P
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
    Costeloe K; Bowler U; Brocklehurst P; Hardy P; Heal P; Juszczak E; King A; Panton N; Stacey F; Whiley A; Wilks M; Millar MR
    Health Technol Assess; 2016 Aug; 20(66):1-194. PubMed ID: 27594381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
    Patole S; Keil AD; Chang A; Nathan E; Doherty D; Simmer K; Esvaran M; Conway P
    PLoS One; 2014; 9(3):e89511. PubMed ID: 24594833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.
    Costeloe K; Hardy P; Juszczak E; Wilks M; Millar MR;
    Lancet; 2016 Feb; 387(10019):649-660. PubMed ID: 26628328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial.
    Rougé C; Piloquet H; Butel MJ; Berger B; Rochat F; Ferraris L; Des Robert C; Legrand A; de la Cochetière MF; N'Guyen JM; Vodovar M; Voyer M; Darmaun D; Rozé JC
    Am J Clin Nutr; 2009 Jun; 89(6):1828-35. PubMed ID: 19369375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Two Probiotics on the Preterms' Gut Microbiota.
    Moreno-Sanz B; Montes MT; Manzano S; Espinosa-Martos I; Cárdenas N; Esteban S; Cruz M; Jiménez E; de Pipaón MS
    J Pediatr Gastroenterol Nutr; 2022 Jun; 74(6):e153-e159. PubMed ID: 35221319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
    Rutten NB; Gorissen DM; Eck A; Niers LE; Vlieger AM; Besseling-van der Vaart I; Budding AE; Savelkoul PH; van der Ent CK; Rijkers GT
    PLoS One; 2015; 10(9):e0137681. PubMed ID: 26378926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic supplementation modifies the gut microbiota profile of very low birth weight preterm infants during hospitalization.
    Chang HY; Lin CY; Chiang Chiau JS; Chang JH; Hsu CH; Ko MH; Lee HC
    Pediatr Neonatol; 2024 Jan; 65(1):55-63. PubMed ID: 37500417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Enteric Supplementation of Probiotics on Late-onset Sepsis by Candida species in Preterm Low Birth Weight Neonates: A Randomized, Double Blind, Placebo-controlled Trial.
    Roy A; Chaudhuri J; Sarkar D; Ghosh P; Chakraborty S
    N Am J Med Sci; 2014 Jan; 6(1):50-7. PubMed ID: 24678479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial.
    Tewari VV; Dubey SK; Gupta G
    J Trop Pediatr; 2015 Oct; 61(5):377-85. PubMed ID: 26246087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics and growth in preterm infants: A randomized controlled trial, PREMAPRO study.
    Hays S; Jacquot A; Gauthier H; Kempf C; Beissel A; Pidoux O; Jumas-Bilak E; Decullier E; Lachambre E; Beck L; Cambonie G; Putet G; Claris O; Picaud JC
    Clin Nutr; 2016 Aug; 35(4):802-11. PubMed ID: 26220763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing
    Wieërs G; Verbelen V; Van Den Driessche M; Melnik E; Vanheule G; Marot JC; Cani PD
    Front Public Health; 2020; 8():578089. PubMed ID: 33763399
    [No Abstract]   [Full Text] [Related]  

  • 15. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.
    Manzoni P; Rinaldi M; Cattani S; Pugni L; Romeo MG; Messner H; Stolfi I; Decembrino L; Laforgia N; Vagnarelli F; Memo L; Bordignon L; Saia OS; Maule M; Gallo E; Mostert M; Magnani C; Quercia M; Bollani L; Pedicino R; Renzullo L; Betta P; Mosca F; Ferrari F; Magaldi R; Stronati M; Farina D;
    JAMA; 2009 Oct; 302(13):1421-8. PubMed ID: 19809023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of probiotic supplementation on the gut microbiota of preterm infants.
    Plummer EL; Danielewski JA; Garland SM; Su J; Jacobs SE; Murray GL
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34431764
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial.
    Chen MJ; Chen CC; Huang YC; Tseng CC; Hsu JT; Lin YF; Fang YJ; Wu MS; Liou JM;
    Helicobacter; 2021 Dec; 26(6):e12857. PubMed ID: 34708471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.
    Manzoni P; Mostert M; Leonessa ML; Priolo C; Farina D; Monetti C; Latino MA; Gomirato G
    Clin Infect Dis; 2006 Jun; 42(12):1735-42. PubMed ID: 16705580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants.
    Garland SM; Tobin JM; Pirotta M; Tabrizi SN; Opie G; Donath S; Tang ML; Morley CJ; Hickey L; Ung L; Jacobs SE;
    BMC Infect Dis; 2011 Aug; 11():210. PubMed ID: 21816056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preterm gut microbiota and administration routes of different probiotics: a randomized controlled trial.
    Rahkola EN; Rautava S; Hiltunen H; Ross C; Lahti L; Isolauri E
    Pediatr Res; 2023 Oct; 94(4):1480-1487. PubMed ID: 37020105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.